# ANEKABIO LLC: Development and Validation of Efficacy Biomarkers for QTE Therapy in Friedreich's Ataxia

**Lab Budget Score:** 40/100

| Field | Value |
|---|---|
| Organization | ANEKABIO LLC |
| Location | GAINESVILLE, FL |
| Project | Development and Validation of Efficacy Biomarkers for QTE Therapy in Friedreich's Ataxia |
| Project number | 5R41NS143585-02 |
| Mechanism | R41 |
| Institute | National Institute of Neurological Disorders and Stroke |
| Award | $245,560 |
| Awarded | 2026-09-04 |
| Project period | 2025-09-23 to 2027-08-31 |
| UEI | JRP2ABF81TZ8 |

## Why this score
- Award of $245,560.
- Research or center grant: supplies, instruments and services budget.

Source: NIH RePORTER (newly awarded projects) (https://reporter.nih.gov/project-details/11420527). Last refreshed: 2026-11-03T18:16:24.961Z.
Award data comes from NIH RePORTER and may be revised by NIH. Organization-level only; investigator names and contacts are not included. Informational only.